IL15 and non-small cell lung carcinoma: <b>Conclusions</b>: Distinct inflammatory and mitochondrial biomarkers tracked cachexia evolution in advanced NSCLC, with early GDF-15/IL-15 elevations and later increases in circulating mtDNA.